A long-standing and fundamental problem of classifying spinal injury based on presumed mechanism of injury is that the same mechanism of injury can result in morphologically different patterns of injury; similar morphologic patterns of injury can also be the result of different injury mechanisms, and the patterns of head deflection do not predict spinal injury patterns. Several characteristics of the injury force that determine the extent of neural tissue damage have been identified. These include the rate of force application, the degree of neural tissue compression, and the duration of neural tissue compression.
Primary Injury
Primary injury refers to physical tissue disruption caused by mechanical forces.
- Contusion: This sudden, brief compression by a displaced structure affects central tissues primarily and accounts for the majority of primary injuries; thus, it is responsible for the majority of neurologic deficits. Contusion injuries are potentially reversible, although irreversible neuronal death occurs along with vascular injury and intramedullary hemorrhage.
- Compression: Injury results from decreased size of the spinal canal; it may occur with translation or angulation of the spinal column, as in burst injuries or epidural hematomas. Injury occurs by:
- Mechanical deformation interrupting axonal flow
- Interruption of spinal vascularity resulting in ischemia of neurologic structures
- Stretch: Injury results in longitudinal traction, as in the case of a flexiondistraction injury. Injury occurs as a result of capillary and axonal collapse secondary to tensile distortion.
- Laceration: This is caused by penetrating foreign bodies, missile fragments, or displaced bone.
Secondary Injury
Secondary injury refers to additional neural tissue damage resulting from the biologic response initiated by physical tissue disruption. Local tissue elements undergo structural and chemical changes. These changes, in turn, elicit systemic responses. Changes in local blood flow, tissue edema, metabolite concentrations, and concentrations of chemical mediators lead to propagation of interdependent reactions. This pathophysiologic response, referred to as secondary injury, can propagate tissue destruction and functional loss.
The functional consequences of spinal cord injury are usually described by terms that refer to the severity and pattern of neurologic dysfunction: Complete spinal cord injury, incomplete injury, and transient spinal cord dysfunction describe different grades of severity of neurologic injury. Names for different types of spinal cord injury syndromes, such as anterior cord syndrome, central cord syndrome, and Brown-Séquard syndrome, refer to patterns of neurologic dysfunction observed during clinical evaluation.
Grading of Neurologic Injury
Spinal Cord Injury: Complete
- No sensation or voluntary motor function is noted caudal to the level of injury in the presence of an intact bulbocavernosus reflex. (The sacral levels are commonly quoted as being S2, S3, and S4.)
- Reflex returns below the level of the cord injury.
- The level of injury is named by the last spinal level of partial neurologic function.
- One can expect up to one to two levels of additional root return, although the prognosis for recovery is extremely poor.
Spinal Cord Injury: Incomplete
- Some neurologic function persists caudal to the level of injury after the return of the bulbocavernosus reflex.
- As a rule, the greater the function distal to the lesion and the faster the recovery, the better is the prognosis.
- Sacral sparing is represented by perianal sensation, voluntary rectal motor function, and great toe flexor activity; it indicates at least partial continuity of white matter long tracts (corticospinal and spinothalamic) with implied continuity between the cerebral cortex and lower sacral motor neurons. It indicates incomplete cord injury, with the potential for a greater return of cord function following resolution of spinal shock.
Patterns of Incomplete Spinal Cord Injury
Brown-Séquard Syndrome
- This is a hemicord injury with ipsilateral muscle paralysis, loss of proprioception and light touch sensation, and contralateral hypesthesia to pain and temperature.
- The prognosis is good, with over 90% of patients regaining bowel and bladder function and ambulatory capacity.
Central Cord Syndrome
- This is most common and is frequently associated with an extension injury to an osteoarthritic spine in a middle-aged person.
- It presents with flaccid paralysis of the upper extremities (more involved) and spastic paralysis of the lower extremities (less involved), with the presence of sacral sparing.
- Radiographs frequently demonstrate no fracture or dislocation because the lesion is created by a pincer effect between anterior osteophytes and posterior infolding of the ligamentum flavum.
- The prognosis is fair, with 50% to 60% of patients regaining motor and sensory function to the lower extremities, although permanent central gray matter destruction results in poor hand function.
Anterior Cord Syndrome
- This is common and involves motor and pain/temperature loss (corticospinal and spinothalamic tracts) with preserved light touch and proprioception (dorsal columns).
- The prognosis is good if recovery is evident and progressive within 24 hours of injury. Absence of sacral sensation to temperature or pinprick after 24 hours portends a poor outcome, with functional recovery in 10% of patients according to one series.
Posterior Cord Syndrome
- This is rare and involves loss sensation of deep pressure, deep pain, and proprioception with full voluntary power, pain, and temperature sensation.
Conus Medullaris Syndrome
- This is seen in T12L1 injuries and involves a loss of voluntary bowel and bladder control (S2S4 parasympathetic control) with preserved lumbar root function.
- It may be complete or incomplete; the bulbocavernosus reflex may be permanently lost.
- It is uncommon as a pure lesion and more common with an associated lumbar root lesion (mixed conuscauda lesion).
Nerve Root Lesions
- Isolated root lesions may occur at any level and may accompany spinal cord injury.
- This may be partial or complete and results in radicular pain, sensory dysfunction, weakness, hyporeflexia, or areflexia.
Cauda Equina Syndrome
- This is caused by multilevel lumbosacral root compression within the lumbar spinal canal.
- Clinical manifestations include saddle anesthesia, bilateral radicular pain, numbness, weakness, hyporeflexia or areflexia, and loss of voluntary bowel or bladder function.
Grading Systems for Spinal Cord Injury
Frankel Classification
- Grade A: Absent motor and sensory function
- Grade B: Absent motor function; sensation present
- Grade C: Motor function present but not useful (2/5 or 3/5); sensation present
- Grade D: Motor function present and useful (4/5); sensation present
- Grade E: Normal motor (5/5) and sensory function
American Spinal Injury Association Impairment Scale
- Grade A: Complete: No motor or sensory function is preserved in sacral segments S4S5.
- Grade B: Incomplete: Sensory but not motor function is preserved below the neurologic level and extends through the sacral segment S4S5.
- Grade C: Incomplete: Motor function is preserved below the neurologic level; most key muscles below the neurologic level have a muscle grade <3.
- Grade D: Incomplete: Motor function is preserved below the neurologic level; most key muscles below the neurologic level have a muscle grade >3.
- Grade E: Normal: Motor and sensory function is normal.
American Spinal Injury Association Neurologic Assessment (Fig. 8.1)
- According to American Spinal Injury Association (ASIA) definitions, the neurologic injury level is the most caudal segment of the spinal cord with normal motor and sensory function on both sides: right and left sensation and right and left motor function.
- For functional scoring, 10 key muscle segments corresponding to innervation by C5, C6, C7, C8, T1, L2, L3, L4, L5, and S1 are each given a functional score of 0 to 5 out of 5.
- For sensory scoring, both right and left sides are graded for a total of 100 points. For the 28 sensory dermatomes on each side of the body, sensory levels are scored on a 0- to 2-point scale, yielding a maximum possible pinprick score of 112 points for a patient with normal sensation.
Note: Specific fractures of the cervical and thoracolumbar spines are covered in their respective chapters.
Immobilization
- A rigid cervical collar is indicated until the patient is cleared radiographically and clinically. A patient with a depressed level of consciousness (e.g., from ethanol intoxication) cannot be cleared clinically.
- A special backboard with a head cutout must be used for children to accommodate their proportionally larger head size and prominent occiput.
- The patient should be removed from the backboard (by logrolling) as soon as possible to minimize pressure sore formation.
Medical Management of Acute Spinal Cord Injury
- Intravenous methylprednisolone
- May improve recovery of neurologic injury
- The efficacy of spinal cord injury steroid protocols is controversial. Although it is not considered standard of care in many centers, some institutions continue to employ the protocol if administered within 8 hours of injury. The increased risk of complications such as gastrointestinal hemorrhage, wound infection, sepsis, and pneumonia and its questionable efficacy have resulted in the trend away from use of methylprednisolone.
- For those who advocate its use, there is a loading dose of 30 mg/kg.
- 5.4 mg/kg/hour over the next 24 hours if started within 3 hours of spinal cord injury
- 5.4 mg/kg/hour over the next 48 hours if started within 8 hours of spinal cord injury
- Is not indicated for pure root lesions
- Experimental pharmacologic agents include:
- Naloxone (opiate receptor antagonist)
- Thyrotropin-releasing hormone
- GM1 gangliosides: a membrane glycolipid that, when administered within 72 hours of injury, resulted in a significant increase in motor scores. Administer 100 mg per day for up to 32 days after injury. It is not recommended for simultaneous use with methylprednisolone.
- Riluzole (sodium channel blocker) U.S. Food and Drug Administration (FDA)-approved for use in amyotrophic lateral sclerosis (ALS): It blocks pathologic activation of sodium channels reducing glutamate release.